4.7 Article

BMP signaling in development and diseases: A pharmacological perspective

期刊

BIOCHEMICAL PHARMACOLOGY
卷 85, 期 7, 页码 857-864

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2013.01.004

关键词

BMP; Wnt; FGF; Cartilage; Bone

资金

  1. Department of Biotechnology [BT/IN/DENMARK/02/PDN/2011]
  2. Department of Science and Technology [SR/SO/AS-16/2010]
  3. Indian Institute of Technology Kanpur

向作者/读者索取更多资源

Bone morphogenetic protein (BMP) signaling has been implicated in several processes during embryonic development and in adult tissue homeostasis. Maintenance of many organs such as skin, intestinal villi, bones and bone marrow requires continuous regeneration and subsequent differentiation of stem cells in order to maintain organ shape and size necessary for proper functioning. Although BMPs were initially identified as osteogenic factors present in demineralized bone capable of inducing ectopic bone formation, it is now evident that BMPs perform several other functions during embryonic development as well as during the adult life of an organism. Many disorders have been linked to either the BMPs or the molecules functioning downstream of BMP signaling pathway. This review summarizes the existing literature describing the role of BMP signaling during embryonic development and in adult tissue homeostasis to provide a perspective on pharmacological interventions of BMP signaling pathway to mitigate several disease conditions. (c) 2013 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

BMP signaling is required for adult skeletal homeostasis and mediates bone anabolic action of parathyroid hormone

Mohd Parvez Khan, Kainat Khan, Prem Swaroop Yadav, Abhishek Kumar Singh, Aditi Nag, Paritosh Prasahar, Monika Mittal, Shyamsundar Pal China, Mahesh Chandra Tewari, Geet Kumar Nagar, Deepshikha Tewari, Arun Kumar Trivedi, Sabyasachi Sanyal, Amitabha Bandyopadhyay, Naibedya Chattopadhyay

Article Endocrinology & Metabolism

Characterization of BMP signaling dependent osteogenesis using a BMP depletable avianized bone marrow stromal cell line (TVA-BMSC)

Prem Swaroop Yadav, Mohd. Parvez Khan, Paritosh Prashar, Shivali Duggal, Srikanta Kumar Rath, Naibedya Chattopadhyay, Amitabha Bandyopadhyay

Article Cell Biology

Mouse bone marrow stromal cells differentiate to neuron-like cells upon inhibition of BMP signaling

Monika Saxena, Paritosh Prashar, Prem Swaroop Yadav, Jonaki Sen

DIFFERENTIATION (2016)

Article Developmental Biology

A comprehensive mRNA expression analysis of developing chicken articular cartilage

Pratik Narendra Pratap Singh, Ayan Ray, Kimi Azad, Amitabha Bandyopadhyay

GENE EXPRESSION PATTERNS (2016)

Article Multidisciplinary Sciences

Induced GnasR201H expression from the endogenous Gnas locus causes fibrous dysplasia by up-regulating Wnt/β-catenin signaling

Sanjoy Kumar Khan, Prem Swaroop Yadav, Gene Elliott, Dorothy Zhang Hu, Ruoshi Xu, Yingzi Yang

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Correction Cell Biology

Mouse bone marrow stromal cells differentiate to neuron-like cells upon inhibition of BMP signaling (vol 92, pg 1, 2016)

Monika Saxena, Paritosh Prashar, Prem Swaroop Yadav, Jonaki Sen

DIFFERENTIATION (2020)

Article Biology

Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ss-satenin

Taifeng Zhou, Bo Gao, Yi Fan, Yuchen Liu, Shuhao Feng, Qian Cong, Xiaolei Zhang, Yaxing Zhou, Prem S. Yadav, Jiachen Lin, Nan Wu, Liang Zhao, Dongsheng Huang, Shuanhu Zhou, Peiqiang Su, Yingzi Yang

Article Multidisciplinary Sciences

Stat3 loss in mesenchymal progenitors causes Job syndrome-like skeletal defects by reducing Wnt/β-catenin signaling

Prem Swaroop Yadav, Shuhao Feng, Qian Cong, Hanjun Kim, Yuchen Liu, Yingzi Yang

Summary: Job syndrome is a rare genetic disorder characterized by immune dysfunction and skeletal developmental abnormalities. Current treatment options are limited, but enhancing Wnt/β-catenin signaling could potentially reduce bone symptoms in patients with Job syndrome.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Meeting Abstract Endocrinology & Metabolism

Signaling pathways involved in Phosphate (Pi) induced apoptosis of hypertrophic chondrocytes.

Prem Swaroop Yadav, Garyfallia Papaioannou, Marie B. Demay

JOURNAL OF BONE AND MINERAL RESEARCH (2022)

Meeting Abstract Endocrinology & Metabolism

A Novel Mouse Model of Fibrous Dysplasia Reveals Both Cell autonomous and Non Cell-autonomous Function of GαsR201H Mutation.

Sanjoy Khan, Prem Yadav, Yingzi Yang, Gene Elliot

JOURNAL OF BONE AND MINERAL RESEARCH (2017)

Meeting Abstract Endocrinology & Metabolism

BMP2/4 ARE KEY REGULATORS OF ADULT SKELETAL HOMEOSTASIS AND PREREQUISITE FOR BONE ANABOLIC ACTION OF PTH

M. P. Khan, K. Khan, P. S. Yadav, A. K. Singh, A. Nag, A. Bandyopadhyay, N. Chattopadhyay

OSTEOPOROSIS INTERNATIONAL (2016)

Article Pharmacology & Pharmacy

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Paola Orlandi, Marta Banchi, Francesca Vaglini, Marco Carli, Stefano Aringhieri, Arianna Bandini, Carla Pardini, Cristina Viaggi, Michele Lai, Greta Ali, Alessandra Ottani, Eleonora Vandini, Patrizia Guidi, Margherita Bernardeschi, Veronica La Rocca, Giulio Francia, Gabriella Fontanini, Mauro Pistello, Giada Frenzilli, Daniela Giuliani, Marco Scarselli, Guido Bocci

Summary: This study investigates the role of MC4R in melanoma and the use of the selective antagonist ML in combination with vemurafenib. The results show that ML can inhibit melanoma cell proliferation and induce apoptosis through the inhibition of ERK1/2 phosphorylation and reduction of BCL-XL expression. The combination of vemurafenib and ML exhibits a synergistic effect in vitro and inhibits tumor growth in vivo without causing adverse effects.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Cardiac human bitter taste receptors contain naturally occurring variants that alter function

Conor J. Bloxham, Katina D. Hulme, Fabrizio Fierro, Christian Fercher, Cassandra L. Pegg, Shannon L. O'Brien, Simon R. Foster, Kirsty R. Short, Sebastian G. B. Furness, Melissa E. Reichelt, Masha Y. Niv, Walter G. Thomas

Summary: Bitter taste receptors (T2Rs) are a type of G protein-coupled receptors that allow humans to detect aversive and toxic substances. This study characterized the functional properties of previously identified T2Rs in human cardiac tissues and their naturally occurring polymorphisms. The results showed differences in signaling among different T2R variants, and revealed a potential association between the T2R50 Tyr203 variant and cardiovascular disease.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Carfilzomib suppressed LDHA-mediated metabolic reprogramming by targeting ATF3 in esophageal squamous cell carcinoma

Lu Chen, Huanying Shi, Wenxin Zhang, Yongjun Zhu, Haifei Chen, Zimei Wu, Huijie Qi, Jiafeng Liu, Mingkang Zhong, Xiaojin Shi, Tianxiao Wang, Qunyi Li

Summary: This study demonstrates that Carfilzomib exhibits potent anti-tumor activity against esophageal squamous cell carcinoma (ESCC) by triggering mitochondrial apoptosis and reprogramming cellular metabolism. It has been identified that activating transcription factor 3 (ATF3) plays a crucial role as a cellular target in ESCC cells treated with Carfilzomib. Overexpression of ATF3 effectively counteracts the effects of Carfilzomib on ESCC cell proliferation, apoptosis, and metabolic reprogramming. Furthermore, ATF3 mediates the anti-tumor activity of Carfilzomib, suggesting its potential as a therapeutic agent for ESCC.

BIOCHEMICAL PHARMACOLOGY (2024)

Review Pharmacology & Pharmacy

Ferroptosis resistance in cancer: recent advances and future perspectives

Xing Zhang, Xiang Li, Ran Xia, Hong-Sheng Zhang

Summary: This review summarizes recent progress on the mechanisms of ferroptosis resistance in cancer and highlights the role of redox status and metabolism. Combination therapy for ferroptosis has great potential in treating resistant malignant tumors.

BIOCHEMICAL PHARMACOLOGY (2024)